Cataleptic effects of γ-hydroxybutyrate (GHB), its precursor γ-butyrolactone (GBL), and GABAB receptor agonists in mice: Differential antagonism by the GABAB receptor antagonist CGP35348

Psychopharmacology

Volumn 192, Issue 3, 2007, Pages 407-414

  Koek, Wouter ^a   Mercer, Susan L ^b   Coop, Andrew ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Baclofen; Catalepsy; CGP35348; GABA; GABA B; GBL; GHB; Mice; SKF97541

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; BACLOFEN; GAMMA BUTYROLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

4-BUTYROLACTONE; ANIMALS; BACLOFEN; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; GABA ANTAGONISTS; MALE; MICE; MICE, INBRED C57BL; NARCOLEPSY; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, GABA-B; SODIUM OXYBATE; SUBSTANCE-RELATED DISORDERS;

EID: 34247871319     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0718-y     Document Type: Article

References (37)

1. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, Maitre M (1982) High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 30:953-961
2. Bonanno G, Raiteri M (1992) Functional evidence for multiple gamma-aminobutyric acid B receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther 262:114-118
3. Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, Minardi G, Gessa GL (2001) Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315-321
4. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674
5. Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, France CP (2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors. J Pharmacol Exp Ther 308:182-188
6. Carter LP, Wu H, Chen W, Matthews MM, Mehta AK, Hernandez RJ, Thomson JA, Ticku MK, Coop A, Koek W, France CP (2005) Novel {gamma}-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists. J Pharmacol Exp Ther 313:1314-1323
7. Carter LP, Chen W, Coop A, Koek W, France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538: 85-93
8. Colombo G, Agabio R, Lobina C, Reali R, Gessa GL (1998) Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293-302
9. Fassio A, Bonanno G, Cavazzani P, Raiteri M (1994) Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol 263:311-314
10. B agonists. J Med Chem 38:3297-3312
11. B antagonists. J Med Chem 38:3313-3331
12. Fuller DE, Hornfeldt CS (2003) From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy 23:1205-1209
13. Gonzalez A, Nutt DJ (2005) Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 19:195-204
14. Goodwin AK, Froestl W, Weerts EM (2005) Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology (Berl) 180:342-351
15. Itzhak Y, Ali SF (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci 965:451-460
16. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der PH, Mosbacher J, Brauner-Osborne H, Waldmeier P, Bettler B (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730
17. Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, Coop A, France CP (2004) Discriminative stimulus effects of gamma-hydroxybutyrate in pigeons: role of diazepam-sensitive and -insensitive GABA(A) and GABA(B) receptors. J Pharmacol Exp Ther 308:904-911
18. Koek W, Wu H, Coop A, France CP (2006) Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317:1-9
19. Lanza M, Fassio A, Gemignani A, Bonanno G, Raiteri M (1993) CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol 237:191-195
20. Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, Mosbacher J (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38:1667-1673
21. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361
22. Mamelak M, Escriu JM, Stokan O (1977) The effects of gamma- hydroxybutyrate on sleep. Biol Psychiatry 12:273-288
23. Mathivet P, Bernasconi R, De BJ, Marescaux C, Bittiger H (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist. Eur J Pharmacol 321:67-75
24. Mehta AK, Ticku MK (1987) Baclofen induces catatonia in rats. Neuropharmacology 26:1419-1423
25. Navarro JF, Pedraza C, Martin M, Manzaneque JM, Davila G, Maldonado E (1998) Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. Prog Neuropsychopharmacol Biol Psychiatry 22:835-844
26. Poldrugo F, Addolorato G (1999) The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol 34:15-24
27. Rodgers J, Ashton CH, Gilvarry E, Young AH (2004) Liquid ecstasy: a new kid on the dance floor. Br J Psychiatry 184:104-106
28. Seabrook GR, Howson W, Lacey MG (1990) Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices. Br J Pharmacol 101:949-957
29. Sevak RJ, France CP, Koek W (2004) Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine. Eur J Pharmacol 483:289-293
30. Snead OC III, Liu CC (1984) Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 33:2587-2590
31. Tallarida RJ (2000) Drug synergism and dose-effect data analysis. CRC, Boca Raton
32. Tunnicliff G, Raess BU (2002) Gamma-Hydroxybutyrate (orphan medical). Curr Opin Investig Drugs 3:278-283
33. Waldmeier PC (1991) The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn-Schmiedebergs Arch Pharmakol 343:173-178
34. Winter JC (1981) The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology (Berl) 73:372-375
35. Wong CG, Gibson KM, Snead OC III (2004) From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25:29-34
36. Wullner U, Klockgether T, Schwarz M, Sontag KH (1987) Behavioral actions of baclofen in the rat ventromedial thalamic nucleus: antagonism by delta-aminovalerate. Brain Res 422:129-136
37. Yamada K, Yu B, Gallagher JP (1999) Different subtypes of GABAB receptors are present at pre-and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol 81:2875-2883